✦ LIBER ✦

PCN26 ESTIMATION OF THE EPIDEMIOLOGICAL EFFECT OF RITUXIMAB FOR THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMA

✍ Scribed by WG Barreto; JSR Oliveira; LG Borges; E Santos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN24 Epidemiology of the Non-Hodgkin Ly

✍ Romero martin, R.M.; Chávez Diana, C.D. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Treatment of aggressive Non-Hodgkin's ly

✍ Nicolas Novitzky; Helen S. King; Carol Johnson; Peter Jacobs 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Clinical experience with biweekly CHOP p

✍ David Aguiar Bujanda; José Aguiar Morales; Uriel Bohn Sarmiento; Salvador Saura 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 282 KB

Rituximab for the First-Line Maintenance

✍ Janette Greenhalgh, Adrian Bagust, Angela Boland, Michaela Blundell… 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 284 KB

Rituximab for the Treatment of Non-Hodgk

✍ Professor Fredrick Hagemeister 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 158 KB

EMOP/CA chemotherapy for the treatment o

✍ Glaser, Mark G.; Bagshawe, Kenneth D.; Smith, David B.; Ledermann, Jonathan A.; 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 364 KB